(Q44403272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Topiramate: efficacy and tolerability in children according to epilepsy syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Catherine Chiron

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Yann Mikaeloff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Josette Mancini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sylviane Peudenier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Jean-Michel Pedespan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Louis Vallée

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Jacques Motte

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Marie Bourgeois

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Alexis Arzimanoglou

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Olivier Dulac

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

225-232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate monotherapy for childhood absence seizures: an open label pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

A pilot study of topiramate in the treatment of infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Long-term response to topiramate in patients with West syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

A pilot study of topiramate in children with Lennox-Gastaut syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate in patients with learning disability and refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Childhood head tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate enhances the risk of valproate-associated side effects in three children

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate in the treatment of severe myoclonic epilepsy in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate: a review of its use in childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Antiepileptic drugs as a cause of worsening seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Assessing risk to benefit ratio in antiepileptic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate and metabolic acidosis in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

Clinical experience with topiramate dosing and serum levels in children 12 years or under with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900028-7

7 January 2021

10.1016/S0920-1211(03)00028-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694931%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference